ACE/NEP inhibitors (Schering-Plough)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug NameACE/NEP inhibitors (Schering-Plough)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsEndopeptidases inhibitors
TargetsAngiotensin-converting enzymeEndopeptidases
Therapy Area/IndicationsHypertensionHeart FailureCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough Corp
Active IndicationsN/A
Inactive IndicationsHypertensionHeart FailureCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A